Literature DB >> 8405411

Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain.

K Kaupmann1, C Bruns, D Hoyer, K Seuwen, H Lübbert.   

Abstract

The mRNA distribution in the brain and the coupling to cellular effector systems of four somatostatin receptors (SSTR1-4) was studied. All four SRIF receptor subtypes were expressed in cortex and hippocampus. In addition, SSTR1 mRNA was relatively abundant in the spinal cord whereas SSTR2 mRNA was also present in the striatum. The SSTR3 gene was predominantly expressed in the olfactory bulb and in the cerebellum. Conflicting results about the effector coupling of SSTR1-3 have been published previously. We have stably expressed human SSTR1-4 in HEK 293 human embryonal kidney cells. Agonist binding to the receptor subtypes, including the recently cloned SSTR4, inhibited the formation of forskolin-induced cAMP. Is is concluded that, in an appropriate cellular environment, all four receptor subtypes can functionally couple to the inhibition of adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405411     DOI: 10.1016/0014-5793(93)80296-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.

Authors:  H Boudin; P Sarret; J Mazella; A Schonbrunn; A Beaudet
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways.

Authors:  Renzo Cescato; Kimberly A Loesch; Beatrice Waser; Helmut R Mäcke; Jean E Rivier; Jean Claude Reubi; Agnes Schonbrunn
Journal:  Mol Endocrinol       Date:  2009-11-12

Review 3.  Somatostatin.

Authors:  T Reisine
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

4.  Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

Authors:  I Shimon; J E Taylor; J Z Dong; R A Bitonte; S Kim; B Morgan; D H Coy; M D Culler; S Melmed
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Authors:  D Macfarlane; J Gonin; D Wieland; T Mangner; J Froelich; W Beierwaltes; B Shapiro
Journal:  Eur J Nucl Med       Date:  1996-02

Review 6.  Molecular pharmacology of somatostatin receptors.

Authors:  D Hoyer; H Lübbert; C Bruns
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

Review 7.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

8.  Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.

Authors:  S W Castro; G Buell; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization.

Authors:  J Pérez; M Rigo; K Kaupmann; C Bruns; K Yasuda; G I Bell; H Lübbert; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

Review 10.  Somatostatin receptors in pituitary and development of somatostatin receptor subtype-selective analogs.

Authors:  Ilan Shimon
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.